FDA Leadership

Enforcement Actions Drop 60%: Pharmaceutical Industry Regulatory Capture of FDA

2023-08-12 00:00:00 +0000 UTC | Importance: 8/10

Internal agency data reveals a dramatic decline in FDA enforcement actions against pharmaceutical companies. Annual warning letters dropped from over 130 in the late 1990s to just three in 2023, indicating a significant reduction in regulatory oversight. Investigations by ProPublica and HHS show …

Regulatory Enforcement Division Industry Trade Groups Congressional Oversight FDA Leadership Pharmaceutical Manufacturers Association enforcement-decline regulatory-capture industry-influence oversight-failure pharmaceutical-industry +1 more

FDA Commissioner Confirmed Amid Pharmaceutical Industry Ties Controversy

2022-03-15 00:00:00 +0000 UTC | Importance: 8/10

Dr. Robert Califf confirmed as FDA Commissioner by a narrow Senate vote of 50-46, highlighting ongoing concerns about pharmaceutical industry regulatory capture. Historical evidence suggests a systemic ‘revolving door’ between FDA and pharmaceutical companies, with approximately 27% of …

Robert Califf Senate FDA Leadership Pharmaceutical Industry Executives regulatory-capture revolving-door pharmaceutical-industry conflict-of-interest senate-confirmation